Not applicableStudy completedNCT02284594What this trial is testingAdult Influenza Vaccination Text Message Reminders With Electronic Health Record AlertsWho this might be right forInfluenza Columbia University 4,026
Post-approval studies (Phase 4)Ended earlyNCT01690637What this trial is testingPanama and El Salvador Children's Oseltamivir StudyWho this might be right forInfluenzaHuman Influenza Centers for Disease Control and Prevention 721
Not applicableStudy completedNCT04963166What this trial is testingNatural History of Systemic and Nasal Mucosal Immunity After Influenza Vaccination in a Pediatric PopulationWho this might be right forInfluenza Immunity National Institute of Allergy and Infectious Diseases (NIAID) 65
Very early researchStudy completedNCT03277456What this trial is testingDetermine the Safety and Immunogenicity of the Candidate Influenza Vaccine MVA-NP+M1Who this might be right forHuman Volunteers Barinthus Biotherapeutics 6
Not applicableStudy completedNCT05009251What this trial is testingUsing Explainable AI Risk Predictions to Nudge Influenza Vaccine UptakeWho this might be right forInfluenzaVaccinationHealth Promotion+2 more National Bureau of Economic Research, Inc. 45,061
Not applicableStudy completedNCT02907645What this trial is testingInfluenza Vaccine Randomized Educational Trial: AdultWho this might be right forVaccinationInfluenza Columbia University 222
Not applicableStudy completedNCT05727202What this trial is testingProject STARFISH - PRJ0002679Who this might be right forSARS-CoV-2 InfectionInfluenza AInfluenza Type B+1 more Thermo Fisher Scientific, Inc 1,909
Large-scale testing (Phase 3)UnknownNCT05093998What this trial is testingStudy Evaluating the Efficacy and Safety of AV5080 in Patients With Uncomplicated InfluenzaWho this might be right forInfluenza Viriom 700
Post-approval studies (Phase 4)Study completedNCT02563093What this trial is testingStudy of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in AdultsWho this might be right forInfluenza Sanofi Pasteur, a Sanofi Company 208
Large-scale testing (Phase 3)Ended earlyNCT03376321What this trial is testingEvaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A InfectionWho this might be right forInfluenza A Janssen Research & Development, LLC 334
Testing effectiveness (Phase 2)Study completedNCT00258934What this trial is testingImmunogenicity Study of the Influenza Vaccine in AdultsWho this might be right forOrthomyxoviridae InfectionsInfluenza Sanofi Pasteur, a Sanofi Company 978
Post-approval studies (Phase 4)Study completedNCT02686398What this trial is testingImmunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing HemodialysisWho this might be right forInfluenzaEnd Stage Renal FailureChronic Kidney Disease Korea University Guro Hospital 174
Post-approval studies (Phase 4)Study completedNCT01691339What this trial is testingStudy of Fluzone® Influenza Virus Vaccines 2012-2013 Formulation Among Adults.Who this might be right forInfluenza Sanofi Pasteur, a Sanofi Company 200
Large-scale testing (Phase 3)Study completedNCT05566639What this trial is testingMRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and OlderWho this might be right forSeasonal Influenza ModernaTX, Inc. 22,502
Testing effectiveness (Phase 2)Study completedNCT02423577What this trial is testingSafety and Protective Efficacy of FF-3 Dry Powder in Healthy Subjects Infected With Influenza Challenge StrainWho this might be right forInfluenza Autoimmune Technologies, LLC 79
Not applicableStudy completedNCT01207557What this trial is testingControlled Trial of the Effectiveness of the Ottawa Influenza Decision AidWho this might be right forInfluenza Ottawa Hospital Research Institute 300
Post-approval studies (Phase 4)Study completedNCT00133588What this trial is testingProteomic Profiling for InfluenzaWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 150
Early research (Phase 1)UnknownNCT04629105What this trial is testingRegenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)Who this might be right forARDS, HumanCovid19 Longeveron Inc. 70
Testing effectiveness (Phase 2)Study completedNCT02213354What this trial is testingH7N9 Mix and Match With MF59 in Healthy Elderly PersonsWho this might be right forAvian Influenza National Institute of Allergy and Infectious Diseases (NIAID) 479
Not applicableUnknownNCT05944705What this trial is testingCommercially Available Cannabis Products for Immune SupportWho this might be right forInfluenzaCOVID-19Common Cold Center For Interventional Pain and Spine 200